Westside Investment Management, Inc. Abb Vie Inc. Transaction History

Westside Investment Management, Inc.

$470 Billion
Q3 2024

A detailed history of Westside Investment Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Westside Investment Management, Inc. holds 17,296 shares of ABBV stock, worth $3.11 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

17,296

Previous 17,125 1.0%

Holding current value

$3.11 Million

Previous $2.94 Billion 15.87%

% of portfolio

0.72%

Previous 0.67%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 20, 2024	BUY	$163.84 - $199.33 $28,016 - $34,085	171 Added 1.0%	17,296 $3.4 Billion
Q2 2024 Jul 17, 2024	SELL	$154.79 - $180.76 $42,412 - $49,528	-274 Reduced 1.57%	17,125 $2.94 Billion
Q1 2024 Apr 19, 2024	SELL	$159.82 - $182.1 $78,311 - $89,229	-490 Reduced 2.74%	17,399 $3.17 Billion
Q4 2023 Jan 12, 2024	SELL	$137.6 - $154.97 $19,264 - $21,695	-140 Reduced 0.78%	17,889 $2.77 Billion
Q2 2023 Jul 14, 2023	SELL	$132.51 - $164.9 $13,251 - $16,490	-100 Reduced 0.55%	18,029 $2.43 Billion
Q1 2023 May 17, 2023	SELL	$144.61 - $166.54 $44,829 - $51,627	-310 Reduced 1.68%	18,129 $2.89 Billion
Q4 2022 Jan 31, 2023	SELL	$138.31 - $165.87 $11,064 - $13,269	-80 Reduced 0.43%	18,439 $283 Million
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $17,447 - $20,010	-130 Reduced 0.7%	18,519 $234 Million
Q2 2022 Jul 15, 2022	SELL	$137.62 - $174.96 $9,633 - $12,247	-70 Reduced 0.37%	18,649 $2.86 Million
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $444,772 - $551,837	-3,370 Reduced 15.26%	18,719 $3.03 Million
Q4 2021 Feb 15, 2022	SELL	$107.43 - $135.93 $29,006 - $36,701	-270 Reduced 1.21%	22,089 $2.99 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $148,321 - $168,367	1,394 Added 6.65%	22,359 $2.41 Million
Q2 2021 Jul 28, 2021	SELL	$105.21 - $117.21 $10,521 - $11,721	-100 Reduced 0.47%	20,965 $2.36 Million
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $234,778 - $258,462	2,295 Added 12.23%	21,065 $2.28 Million
Q4 2020 Jan 15, 2021	SELL	$80.49 - $108.67 $5,070 - $6,846	-63 Reduced 0.33%	18,770 $2.01 Million
Q3 2020 Oct 14, 2020	BUY	$85.91 - $100.83 $408,158 - $479,043	4,751 Added 33.74%	18,833 $1.65 Million
Q2 2020 Jul 21, 2020	SELL	$73.37 - $98.18 $122,234 - $163,567	-1,666 Reduced 10.58%	14,082 $1.38 Million
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $744,459 - $1.13 Million	11,542 Added 274.42%	15,748 $1.2 Million
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $5,058 - $6,466	-77 Reduced 1.8%	4,206 $305,000
Q4 2018 Feb 05, 2019	SELL	$77.85 - $96.01 $10,587 - $13,057	-136 Reduced 3.08%	4,283 $394,000
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $4,578 - $5,417	51 Added 1.17%	4,419 $0
Q1 2018 Apr 16, 2018	SELL	$92.01 - $123.21 $58,794 - $78,731	-639 Reduced 12.76%	4,368 $0
Q4 2017 Feb 15, 2018	SELL	$89.56 - $98.21 $102,546 - $112,450	-1,145 Reduced 18.61%	5,007 $0
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $18,859 - $24,089	270 Added 4.59%	6,152 $0
Q2 2017 Aug 15, 2017	BUY	N/A	5,882	5,882 $0

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.

Account

Westside Investment Management, Inc. Abb Vie Inc. Transaction History